CN106279277B - 一种检测蛋白质巯基亚硝基化的荧光探针及其制备和应用 - Google Patents
一种检测蛋白质巯基亚硝基化的荧光探针及其制备和应用 Download PDFInfo
- Publication number
- CN106279277B CN106279277B CN201610647578.5A CN201610647578A CN106279277B CN 106279277 B CN106279277 B CN 106279277B CN 201610647578 A CN201610647578 A CN 201610647578A CN 106279277 B CN106279277 B CN 106279277B
- Authority
- CN
- China
- Prior art keywords
- fluorescence
- probe
- nitrosation
- fluorescence probe
- good
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000000523 sample Substances 0.000 title claims abstract description 36
- 238000007034 nitrosation reaction Methods 0.000 title claims abstract description 9
- 238000002360 preparation method Methods 0.000 title description 5
- 238000001514 detection method Methods 0.000 claims abstract description 18
- 230000004048 modification Effects 0.000 claims abstract description 16
- 238000012986 modification Methods 0.000 claims abstract description 16
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims abstract description 15
- 230000006295 S-nitrosylation Effects 0.000 claims abstract description 10
- XXYNZSATHOXXBJ-UHFFFAOYSA-N 4-hydroxyisoindole-1,3-dione Chemical group OC1=CC=CC2=C1C(=O)NC2=O XXYNZSATHOXXBJ-UHFFFAOYSA-N 0.000 claims abstract description 3
- 235000010233 benzoic acid Nutrition 0.000 claims abstract description 3
- 238000006482 condensation reaction Methods 0.000 claims abstract description 3
- 238000006243 chemical reaction Methods 0.000 claims description 11
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 claims description 6
- 239000001257 hydrogen Substances 0.000 claims description 6
- 229910052739 hydrogen Inorganic materials 0.000 claims description 6
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 6
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 claims description 4
- 229960000549 4-dimethylaminophenol Drugs 0.000 claims description 3
- 238000004440 column chromatography Methods 0.000 claims description 3
- 150000001875 compounds Chemical class 0.000 claims description 3
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 3
- 229920000151 polyglycol Polymers 0.000 claims description 3
- 239000010695 polyglycol Substances 0.000 claims description 3
- 239000005711 Benzoic acid Substances 0.000 claims description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 2
- 150000003839 salts Chemical class 0.000 claims description 2
- 239000002904 solvent Substances 0.000 claims description 2
- 238000006467 substitution reaction Methods 0.000 claims description 2
- 230000035945 sensitivity Effects 0.000 abstract description 4
- 239000012528 membrane Substances 0.000 abstract description 3
- 238000010521 absorption reaction Methods 0.000 abstract description 2
- 239000012472 biological sample Substances 0.000 abstract description 2
- 230000035699 permeability Effects 0.000 abstract description 2
- 150000001559 benzoic acids Chemical class 0.000 abstract 1
- GPAYUJZHTULNBE-UHFFFAOYSA-N diphenylphosphine Chemical compound C=1C=CC=CC=1PC1=CC=CC=C1 GPAYUJZHTULNBE-UHFFFAOYSA-N 0.000 abstract 1
- 238000011895 specific detection Methods 0.000 abstract 1
- HYHSBSXUHZOYLX-WDSKDSINSA-N S-nitrosoglutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CSN=O)C(=O)NCC(O)=O HYHSBSXUHZOYLX-WDSKDSINSA-N 0.000 description 22
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 description 16
- 239000007850 fluorescent dye Substances 0.000 description 16
- 210000004027 cell Anatomy 0.000 description 15
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 9
- 238000000034 method Methods 0.000 description 9
- 102000004169 proteins and genes Human genes 0.000 description 7
- 108090000623 proteins and genes Proteins 0.000 description 7
- 102100031181 Glyceraldehyde-3-phosphate dehydrogenase Human genes 0.000 description 6
- 108010001742 S-Nitrosoglutathione Proteins 0.000 description 6
- 108020004445 glyceraldehyde-3-phosphate dehydrogenase Proteins 0.000 description 6
- 238000012545 processing Methods 0.000 description 6
- 101000688996 Homo sapiens Ski-like protein Proteins 0.000 description 5
- 230000008859 change Effects 0.000 description 5
- 230000001965 increasing effect Effects 0.000 description 5
- 235000018102 proteins Nutrition 0.000 description 5
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 4
- 230000001419 dependent effect Effects 0.000 description 4
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- 238000005375 photometry Methods 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 150000003573 thiols Chemical class 0.000 description 3
- FPQQSJJWHUJYPU-UHFFFAOYSA-N 3-(dimethylamino)propyliminomethylidene-ethylazanium;chloride Chemical compound Cl.CCN=C=NCCCN(C)C FPQQSJJWHUJYPU-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 229960002685 biotin Drugs 0.000 description 2
- 235000020958 biotin Nutrition 0.000 description 2
- 239000011616 biotin Substances 0.000 description 2
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 2
- 235000018417 cysteine Nutrition 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 238000004043 dyeing Methods 0.000 description 2
- 230000004064 dysfunction Effects 0.000 description 2
- 210000002889 endothelial cell Anatomy 0.000 description 2
- 238000003384 imaging method Methods 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- 230000009635 nitrosylation Effects 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 230000007170 pathology Effects 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 150000003384 small molecules Chemical class 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 238000013518 transcription Methods 0.000 description 2
- 230000035897 transcription Effects 0.000 description 2
- DYUUGILMVYJEHY-UHFFFAOYSA-N 1-$l^{1}-oxidanyl-4,4,5,5-tetramethyl-3-oxido-2-phenylimidazol-3-ium Chemical compound CC1(C)C(C)(C)N([O])C(C=2C=CC=CC=2)=[N+]1[O-] DYUUGILMVYJEHY-UHFFFAOYSA-N 0.000 description 1
- 238000005160 1H NMR spectroscopy Methods 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- XFQMMTLBVDYETB-UHFFFAOYSA-N 5-ethyl-4-hydroxyisoindole-1,3-dione Chemical compound OC1=C2C(C(=O)NC2=O)=CC=C1CC XFQMMTLBVDYETB-UHFFFAOYSA-N 0.000 description 1
- 241000931526 Acer campestre Species 0.000 description 1
- KDXKERNSBIXSRK-RXMQYKEDSA-N D-lysine Chemical compound NCCCC[C@@H](N)C(O)=O KDXKERNSBIXSRK-RXMQYKEDSA-N 0.000 description 1
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 1
- ODUCDPQEXGNKDN-UHFFFAOYSA-N Nitrogen oxide(NO) Natural products O=N ODUCDPQEXGNKDN-UHFFFAOYSA-N 0.000 description 1
- PMUHEVHXZGFUAN-CKCBUVOCSA-N OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O.OC(=O)[C@@H](N)CCC(=O)N[C@@H](CSN=O)C(=O)NCC(O)=O Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O.OC(=O)[C@@H](N)CCC(=O)N[C@@H](CSN=O)C(=O)NCC(O)=O PMUHEVHXZGFUAN-CKCBUVOCSA-N 0.000 description 1
- 238000012228 RNA interference-mediated gene silencing Methods 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- 102000040945 Transcription factor Human genes 0.000 description 1
- 108091023040 Transcription factor Proteins 0.000 description 1
- 230000001640 apoptogenic effect Effects 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 230000004900 autophagic degradation Effects 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 239000006143 cell culture medium Substances 0.000 description 1
- 230000022131 cell cycle Effects 0.000 description 1
- 230000003915 cell function Effects 0.000 description 1
- 230000004656 cell transport Effects 0.000 description 1
- 238000004737 colorimetric analysis Methods 0.000 description 1
- 238000004624 confocal microscopy Methods 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 125000000151 cysteine group Chemical group N[C@@H](CS)C(=O)* 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 125000003963 dichloro group Chemical group Cl* 0.000 description 1
- YDVNLQGCLLPHAH-UHFFFAOYSA-N dichloromethane;hydrate Chemical compound O.ClCCl YDVNLQGCLLPHAH-UHFFFAOYSA-N 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000002848 electrochemical method Methods 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000005357 flat glass Substances 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 230000009368 gene silencing by RNA Effects 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 210000003470 mitochondria Anatomy 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- 238000006011 modification reaction Methods 0.000 description 1
- SVEUVITYHIHZQE-UHFFFAOYSA-N n-methylpyridin-2-amine Chemical compound CNC1=CC=CC=N1 SVEUVITYHIHZQE-UHFFFAOYSA-N 0.000 description 1
- 230000007830 nerve conduction Effects 0.000 description 1
- 238000006396 nitration reaction Methods 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- GQPLMRYTRLFLPF-UHFFFAOYSA-N nitrous oxide Inorganic materials [O-][N+]#N GQPLMRYTRLFLPF-UHFFFAOYSA-N 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 239000012044 organic layer Substances 0.000 description 1
- 230000002018 overexpression Effects 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 210000002381 plasma Anatomy 0.000 description 1
- 239000013612 plasmid Substances 0.000 description 1
- 238000012805 post-processing Methods 0.000 description 1
- 230000004481 post-translational protein modification Effects 0.000 description 1
- 230000012846 protein folding Effects 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- -1 react 15 minutes Chemical compound 0.000 description 1
- 238000006578 reductive coupling reaction Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000011896 sensitive detection Methods 0.000 description 1
- 238000010898 silica gel chromatography Methods 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 230000004697 synapse damage Effects 0.000 description 1
- 230000033772 system development Effects 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 238000001890 transfection Methods 0.000 description 1
- 239000012096 transfection reagent Substances 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
- RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 description 1
- 210000003606 umbilical vein Anatomy 0.000 description 1
- 210000003556 vascular endothelial cell Anatomy 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
- C07F9/572—Five-membered rings
- C07F9/5728—Five-membered rings condensed with carbocyclic rings or carbocyclic ring systems
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K11/00—Luminescent, e.g. electroluminescent, chemiluminescent materials
- C09K11/06—Luminescent, e.g. electroluminescent, chemiluminescent materials containing organic luminescent materials
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/6486—Measuring fluorescence of biological material, e.g. DNA, RNA, cells
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
- C09K2211/10—Non-macromolecular compounds
- C09K2211/1018—Heterocyclic compounds
- C09K2211/1025—Heterocyclic compounds characterised by ligands
- C09K2211/1029—Heterocyclic compounds characterised by ligands containing one nitrogen atom as the heteroatom
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
本发明提供一种检测蛋白质巯基亚硝基化的荧光探针,通过N‑R基取代的3‑羟基邻苯二甲酰亚胺与2‑二苯基磷基苯甲酸在无水二氯甲烷中发生缩合反应制得。本发明提供的荧光探针稳定性好,能够长期保存使用;具有较大的吸收发射波长差(>100nm),能够有效避免激发光的干扰;由于探针在生理环境中本身无荧光,只有在与SNO反应后才有荧光,生成具有强荧光的产物,因此,检测信噪比高,灵敏度好;具有优秀的选择性,能在复杂生物样品中特异性地检测蛋白质S‑亚硝基化;具有良好的生物膜通透性,从而实现对蛋白质巯基亚硝基化修饰的特异性检测。本发明探针的结构通式如下:
Description
技术领域
本发明属生物检测领域,涉及一类检测蛋白质巯基亚硝基化(S-nitrosothiols,SNOs)的荧光探针及其制备方法和应用。
背景技术
蛋白质巯基亚硝基化修饰(S-nitrosylation,S-亚硝基化修饰)是一类依赖于一氧化氮(NO)分子的可逆性蛋白质翻译后修饰。蛋白质结构中位于特定位点的半胱氨酸巯基与NO分子通过选择性氧化还原共价结合,最终半胱氨酸巯基被亚硝基化修饰。蛋白质中的半胱氨酸残基是调节酶活性、转录因子结合、蛋白质折叠和金属结合的关键因素,因此S-亚硝基化修饰对多种细胞功能的发挥和信号通路的调节,例如神经传导、细胞周期调控、细胞运输、转录翻译调控及自噬、凋亡等过程起着重要的调控作用。然而过度S-亚硝基化会触发蛋白质错误折叠、线粒体功能障碍、转录失调、突触损伤及神经元损伤等等细胞功能障碍,进一步引发多种疾病病理进程的发生和发展。近年来蛋白质S-亚硝基化修饰作为一个新兴的研究热点,越来越受到科学家的重视,发展能对生物体内S-亚硝基化修饰进行实时追踪检测的方法,可极大推动相关的生理病理学研究。
早期的S-亚硝基化修饰检测方法主要是利用化学发光法、比色法、电化学分析法测定样本释放的总NO量,但无法区分NO分解自血红素、代谢物还是S-亚硝基化蛋白质,也无法获取蛋白质S-亚硝基化的修饰位点和动态变化等任何信息。目前应用最广泛、体系发展最成熟的是生物素开关法(biotin switch),该法目前虽然接受度高,准确度好,但存在假阳性高、操作步骤繁琐、实验样本浪费率高、选择性和灵敏度有限、很难应用于活细胞成像及在体实时监测等缺点。小分子荧光探针成像由于透膜性好,灵敏度高,操作简单,可用于活体检测,近年来已成为检测完整生物样本的理想而不可缺少的辅助工具。
发明内容
本发明的一个目的是提供一种检测蛋白质巯基亚硝基化的荧光探针,是一类新型的特异性在活细胞中检测蛋白质S-亚硝基化修饰的小分子荧光探针,具有式I所示的结构:
其中,R为氢、C1-C4烷基,或者不同长度的聚乙二醇链其中:R2为氢、甲基或乙基,n为1-4的自然数。
本发明的又一个目的是提供式I所示化合物的制备方法,通过以下步骤实现:以无水二氯甲烷为溶剂,在1-乙基-(3-二甲基氨基丙基)碳酰二亚胺盐酸盐(EDC·HCl)及4-二甲氨基吡啶(DMAP)的存在条件下,N-R基取代的3-羟基邻苯二甲酰亚胺与2-二苯基磷基苯甲酸发生缩合反应,并在反应完全后经柱层析纯化,即得式I化合物。反应式如下:
其中,R为氢、C1-C4烷基,或者不同长度的聚乙二醇链其中:R2为氢、甲基或乙基,n为1-4的自然数。
本发明的再一个目的是提供式I所示的荧光探针在检测蛋白质S-亚硝基化修饰中的应用。本发明以活细胞中的应用为例,可通过以下步骤实现:细胞培养基中加入式I所示的荧光探针,使其终浓度为5μM,37℃下孵育30分钟,观察记录细胞荧光强度,本发明提供的荧光探针的特征在于它本身在生理环境中只有微弱的荧光,但可与SNO特异性快速反应,生成具有强荧光的产物,实现1至14倍荧光增强,从而实现蛋白质S-亚硝基化修饰的特异性检测和定量分析。
本发明利用亚硝基化硫醇(SNO)与三苯基磷类化合物间,类似于Staudingerligation的还原偶联反应,设计可与蛋白质中S-亚硝基化位点特异性反应的荧光探针,这些荧光探针本身无荧光,与SNO反应后可生成具有强荧光的产物,因而可用于蛋白质S-亚硝基化修饰程度的灵敏检测。荧光探针法除适用于检测细胞样本、血浆、组织匀浆中S-亚硝基化修饰程度,还适用于活细胞甚至是动物组织中S-亚硝基化修饰的动态检测。
本发明涉及的荧光探针具有以下有益效果:(1)稳定性好,能够长期保存使用;(2)具有较大的吸收发射波长差(>100nm),能够有效避免激发光的干扰;(3)由于探针在生理环境中本身无荧光,只有在与SNO反应后才有荧光,即与巯基亚硝基化修饰的蛋白发生特异性的反应,生成具有强荧光的产物,因此,检测信噪比高,灵敏度好;(4)具有优秀的选择性,能在复杂生物样品中特异性地检测蛋白质S-亚硝基化;(5)具有良好的生物膜通透性,因而能用于活细胞中S-亚硝基化修饰的检测,从而实现对蛋白质巯基亚硝基化修饰的特异性检测。
附图说明
图1是荧光探针分子I-1与S-亚硝基化谷胱甘肽(GSNO)反应前后的荧光变化。
图2是荧光探针分子I-1对GSNO的选择性。
图3是荧光探针分子I-1对GSNO浓度依赖性荧光增强。
图4是荧光探针分子I-1检测活细胞中亚硝酰化蛋白。
图5是荧光探针分子I-1检测活细胞中过表达GAPDH蛋白的巯基亚硝酰化修饰。
具体实施方式
下面结合附图和实施例对本发明做进一步说明,以下的实施例不是限制本发明的范围。
实施例1:荧光探针分子I-1的制备
将2-二苯基磷基苯甲酸92mg(1eq),N-(2-(2-(2-乙氧基)乙氧基)乙氧基)乙基-3-羟基邻苯二甲酰亚胺(2eq),DMAP(0.2eq)放于25mL单口瓶,氮气保护,注入5毫升干燥二氯甲烷,反应15分钟,然后将EDC·HCl(1eq)溶于二氯甲烷,注入,室温搅拌过夜。后处理,加10毫升水,分别用10毫升二氯甲烷萃取三次,合并有机层,无水硫酸钠干燥,减压浓缩后以石油醚和二氯甲烷的混合溶剂洗脱进行硅胶柱层析,过柱色谱,得I-1。1H NMR(500MHz,CDCl3)δ8.42(dd,J=7.0,3.8Hz,1H),7.63–7.55(m,2H),7.45(t,J=7.0Hz,1H),7.41(t,J=7.0Hz,1H),7.31–7.14(m,11H),6.93(dd,J=7.0,3.8Hz,1H),3.74(t,J=5.9Hz,2H),3.60(t,J=5.9Hz,2H),3.56–3.48(m,6H),3.45–3.37(m,4H),1.10(t,J=7.0Hz,3H).
实施例2:荧光探针分子I-1与GSNO反应前后的荧光变化
将探针分子以少量DMSO溶解,分别加入PBS缓冲液或GSNO的PBS溶液,使探针分子的终浓度为5μM,GSNO终浓度为10μM。反应60min后使用荧光分光光计以405nm激发,记录溶液在最大发射波长(约505nm)下的荧光强度,进而确定探针分子与GSNO反应后荧光强度增强,如图1所示。
实施例3:荧光探针分子I-1对GSNO的选择性
将探针分子以少量DMSO溶解,再加入PBS缓冲液配置成溶液,分别加入PBS缓冲液溶解的待测样品,使探针分子的终浓度为5μM,而待测样品终浓度为10μM。反应60min后使用荧光分光光计以405nm激发,记录溶液在最大发射波长(约505nm)下的荧光强度,计算荧光增强倍数,进而确定探针分子对GSNO的选择性,如图2所示。
实施例4:荧光探针分子I-1对GSNO浓度依赖性荧光增强
将探针分子以少量DMSO溶解,再加入PBS缓冲液配置成溶液,分别加入不同浓度的GSNO溶液,使探针分子的终浓度为5μM,反应60min后使用荧光分光光计以405nm激发,记录溶液在最大发射波长(约405nm)下的荧光强度,计算荧光增强倍数,进而确定探针分子对GSNO浓度依赖性荧光增强,如图3所示。
实施例5:荧光探针分子H1检测活细胞中亚硝基化硫醇
将人脐静脉内皮细胞HUVEC接种于多聚赖氨酸包被过的玻片上,含10%胎牛血清的DMEM全培养液中培养24小时后,加入外源性NO供体GSNO(250μM)处理2h。随后换液,加入含有10μM荧光探针H1(10mM,1:1000)的培养液,置于细胞培养箱中37℃孵育1h。细胞玻片经过4%PFA固定7min后,PBS洗3次,加入50μg/ml RNAase 37℃处理30min排除RNA干扰,随后进行细胞核定位PI染色,封片。采用激光共聚焦荧光显微镜观察,拍照。其中分别采用405nm和543nm激光波长激发H1和PI。结果表明,荧光探针分子H1可有效检测到血管内皮细胞中的S-亚硝基化产物,如图4所示。NO清除剂PTIO(150μM)预孵24h处理可使S-亚硝基化探针的荧光亮度在一定程度上有所降低,在这个基础上再给GSNO处理则又能使荧光亮度稍有回升。
此外,我们在内皮细胞HUVEC内过表达GAPDH WT及其亚硝基化位点突变体GAPDHA155S,以提高特异性反应底物水平,考察荧光探针分子H1能否有效检测亚硝基化硫醇的积聚。细胞经Lipo3000转染试剂转染GAPDH WT和GAPDH A155S质粒48-72h后,如上述方法加GSNO处理、荧光探针分子孵育,并进行固定、细胞核PI染色、封片、共聚焦显微镜观察、拍照。结果如图5所示,相较于正常组和突变体组,GSNO处理后过表达GAPDH WT的细胞H1荧光强度明显增强,表明荧光探针分子H1能够有效监测细胞病理损伤过程中S-亚硝基化修饰程度的变化。
Claims (2)
1.一种检测蛋白质巯基亚硝基化的荧光探针,其特征在于,具有式I所示的结构:
其中,R为氢、C1-C4烷基,或者不同长度的聚乙二醇链,其中R2为氢、甲基或乙基,n为1-4的自然数;所述荧光探针通过以下步骤实现:以无水二氯甲烷为溶剂,在1-乙基-(3-二甲基氨基丙基)碳酰二亚胺盐酸盐及4-二甲氨基吡啶的存在条件下,N-R基取代的3-羟基邻苯二甲酰亚胺与2-二苯基磷基苯甲酸发生缩合反应,并在反应完全后经柱层析纯化,即得式I化合物,反应式如下:
。
2.权利要求1所述的一种荧光探针在检测蛋白质S-亚硝基化修饰中的应用。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610647578.5A CN106279277B (zh) | 2016-08-05 | 2016-08-05 | 一种检测蛋白质巯基亚硝基化的荧光探针及其制备和应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610647578.5A CN106279277B (zh) | 2016-08-05 | 2016-08-05 | 一种检测蛋白质巯基亚硝基化的荧光探针及其制备和应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN106279277A CN106279277A (zh) | 2017-01-04 |
CN106279277B true CN106279277B (zh) | 2018-04-10 |
Family
ID=57667013
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610647578.5A Expired - Fee Related CN106279277B (zh) | 2016-08-05 | 2016-08-05 | 一种检测蛋白质巯基亚硝基化的荧光探针及其制备和应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106279277B (zh) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101454921A (zh) * | 2006-04-13 | 2009-06-10 | 南加利福尼亚大学 | 使用邻苯二甲酰亚胺化合物的有机电子器件 |
-
2016
- 2016-08-05 CN CN201610647578.5A patent/CN106279277B/zh not_active Expired - Fee Related
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101454921A (zh) * | 2006-04-13 | 2009-06-10 | 南加利福尼亚大学 | 使用邻苯二甲酰亚胺化合物的有机电子器件 |
Non-Patent Citations (4)
Title |
---|
"A reductive ligation based fluorescent probe for S-nitrosothiols";Di Zhang et al.,;《Chem. Commun.》;20140310;第50卷(第37期);第4806-4809页 * |
4-氨基邻苯二甲酰亚胺衍生物作为荧光探针的应用;史大昕;《化学通报》;20041218(第12期);第904-911页 * |
双酰亚胺类蛋白质荧光探针的合成;史大昕等;《精细化工》;20040430;第21卷(第4期);第245-248页 * |
蛋白质亚硝基化检测和鉴定方法的研究进展;汪达丽等;《植物生理学报》;20140812;第50卷(第8期);第1079-1088页 * |
Also Published As
Publication number | Publication date |
---|---|
CN106279277A (zh) | 2017-01-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Li et al. | A two-photon NIR-to-NIR fluorescent probe for imaging hydrogen peroxide in living cells | |
Tian et al. | Discriminating live and dead cells in dual-color mode with a two-photon fluorescent probe based on ESIPT mechanism | |
Guan et al. | A near-infrared fluorescent sensor for selective detection of cysteine and its application in live cell imaging | |
You et al. | A new tetraphenylethylene‐derived fluorescent probe for nitroreductase detection and hypoxic‐tumor‐cell imaging | |
CN106279278A (zh) | 一种具有线粒体靶向和双光子性质的硫化氢分子荧光探针及其制备方法和应用 | |
CN107089937A (zh) | 线粒体靶向测定粘度的荧光探针及其制备方法和应用 | |
Wei et al. | o‐Fluorination of Aromatic Azides Yields Improved Azido‐Based Fluorescent Probes for Hydrogen Sulfide: Synthesis, Spectra, and Bioimaging | |
CN106243170B (zh) | 具有聚集诱导荧光增强特性的β-半乳糖苷酶传感器的合成及应用 | |
Hou et al. | Sensitive detection and imaging of endogenous peroxynitrite using a benzo [d] thiazole derived cyanine probe | |
CN104710979A (zh) | 一种用于检测谷胱甘肽的荧光探针及其制备方法与应用 | |
CN103173212A (zh) | 一种检测生物硫化氢的荧光探针及其制备与应用 | |
CN106967102A (zh) | 一种基于罗丹明衍生物的过氧化氢增强型荧光探针 | |
Xu et al. | A fast-responsive two-photon fluorescent turn-on probe for nitroreductase and its bioimaging application in living tissues | |
Resa et al. | New dual fluorescent probe for simultaneous biothiol and phosphate bioimaging | |
Jiao et al. | One step synthesis of red-emitting fluorescence turn-on probe for nitroreductase and its application to bacterial detection and oral cancer cell imaging | |
CN110092773A (zh) | 一种氧杂蒽类衍生物及其制备方法和应用 | |
CN109776564A (zh) | 一种氧杂蒽结构的亚铁离子荧光探针及其合成方法和应用 | |
Yang et al. | Red/NIR neutral BODIPY-based fluorescent probes for lighting up mitochondria | |
CN110357865A (zh) | 一种用于检测hNQO1酶的近红外荧光探针及其合成方法和应用 | |
Zhang et al. | Red emissive fluorescent probe for the rapid detection of selenocysteine | |
CN105985769B (zh) | 一种苯硫酚荧光探针的制备及应用 | |
CN108641710A (zh) | 一种检测蛋白质硫巯基化的荧光探针及其制备方法和应用 | |
Wu et al. | Development of near-infrared xanthene fluorescence probe for the highly selective and sensitive detection of cysteine | |
UmuráKaya | Fluorescein propiolate: a propiolate-decorated fluorescent probe with remarkable selectivity towards cysteine | |
CN112266351A (zh) | 一种双光子比率荧光探针及其制备方法与应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20180410 |
|
CF01 | Termination of patent right due to non-payment of annual fee |